SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: mesaone who wrote (523)3/31/1999 9:08:00 PM
From: Bill Wexler  Read Replies (1) | Respond to of 10293
 
Strong sell/short sell recommendation: Biotime (BTIM)

Now that Hextend has been approved, there will be no further room for speculation. Hextend's market share has been grossly overestimated. I believe this situation is similar to Organogenesis (ORG) and is headed for a similar conclusion.

Short with confidence on any uptick.



To: mesaone who wrote (523)3/31/1999 11:30:00 PM
From: Mama Bear  Read Replies (3) | Respond to of 10293
 
mesaone, thanks for the tipoff. BTIM should be a great short sell early in tomorrow's trading session. I hope I can get shares.

Barb


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News